Group One Trading’s NanoViricides NNVC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-1,500
Closed -$1.76K – 8416
2025
Q1
$1.76K Hold
1,500
– – ﹤0.01% 7037
2024
Q4
$2.14K Buy
+1,500
New +$2.16K ﹤0.01% 6716
2022
Q4
– Sell
-2,200
Closed -$4K – 7816
2022
Q3
$4K Buy
+2,200
New +$4.8K ﹤0.01% 6940
2022
Q1
– Sell
-3,400
Closed -$13K – 8462
2021
Q4
$13K Sell
3,400
-8,100
-70% -$36.9K ﹤0.01% 7230
2021
Q3
$53K Buy
11,500
+7,200
+167% +$30K ﹤0.01% 6498
2021
Q2
$20K Buy
4,300
+4,000
+1,333% +$16.1K ﹤0.01% 7189
2021
Q1
$1K Buy
+300
New +$1.36K ﹤0.01% 7466
2015
Q3
– Sell
-100
Closed -$3K – 5072
2015
Q2
$3K Hold
100
– – ﹤0.01% 4612
2015
Q1
$5K Buy
+100
New +$5.33K ﹤0.01% 4367
2014
Q3
– Sell
-80
Closed -$7K – 5353
2014
Q2
$7K Sell
80
-1,125
-93% -$79.9K ﹤0.01% 4656
2014
Q1
$77K Buy
1,205
+1,140
+1,754% +$97.4K ﹤0.01% 3290
2013
Q4
$6K Buy
+65
New +$6.69K ﹤0.01% 4796

Other funds holding NNVC

Group One Trading's NNVC Position: Q3 2026 in Review

Group One Trading sold out of NanoViricides (NNVC) in Q3 2026, closing a stake of 1,024 shares — an estimated $1.44K sold.

Group One Trading first reported a position in NNVC in Q4 2013 and held it in 17 quarters. The position peaked at $69K in Q1 2014. 24 funds tracked by Wall St. Rank hold NNVC as of Q3 2026.

  • Group One Trading reported no remaining NanoViricides position as of Q3 2026 after selling out during the quarter.
  • Group One Trading sold 1,024 NanoViricides shares in Q3 2026, an estimated $1.44K.
  • Group One Trading first reported a position in NanoViricides in Q4 2013 and held it in 17 quarters.
  • Group One Trading's NanoViricides position peaked at $69K in Q1 2014.
  • 24 funds tracked by Wall St. Rank held NanoViricides as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.